JoAnn Pinkerton, MD
Advertisement
Articles by JoAnn Pinkerton, MD
Elinzanetant shows promise as a new treatment for menopause-related vasomotor symptoms, offering rapid relief and a favorable safety profile.
Advertisement
Latest Updated Articles
Lynkuet Access Program Aims to Help Women Save on Neurokinin-Targeted TherapyPublished: October 24th 2025 | Updated:
Elinzanetant Demonstrates Rapid and Sustained Efficacy in Reducing Vasomotor Symptoms Across OASIS Clinical TrialsPublished: October 23rd 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Common Virus May Hold New Clues to Lupus
2
Expert Discusses Logistical Considerations and Future Research Needs for Radiopharmaceuticals
3
Zongertinib Shows Clinically Meaningful Efficacy in Advanced HER2-Mutant NSCLC
4
SHR-A1811 Plus Pertuzumab Improves Survival in HER2-Positive Metastatic Breast Cancer
5
